$33.54 1.3%
ATRC Stock Price vs. AI Score
Data gathered: May 29

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Atricure (ATRC)

Analysis generated May 20, 2025. Powered by Chat GPT.

Atricure, Inc. is a leading provider of innovative surgical solutions that enable the treatment of complex cardiac conditions. The company specializes in the development, manufacture, and sale of surgical devices designed to create precision lesions for the treatment of cardiac arrhythmias. With a strong focus on innovation and patient outcomes, Atricure is dedicated to advancing the field of cardiac surgery and improving the quality of life for patients.

Read full AI stock Analysis

Stock Alerts - Atricure (ATRC)

company logo Atricure | May 18
Business Outlook among employees is down by 6.3% over the last month.
company logo Atricure | April 30
Price is down by -10.2% in the last 24h.
company logo Atricure | April 10
Price is down by -5.3% in the last 24h.
company logo Atricure | April 9
Price is up by 7.2% in the last 24h.

Download our app to get future alerts delivered in real-time.

About Atricure

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.


Atricure
Price $33.54
Target Price Sign up
Volume 329,330
Market Cap $1.68B
Year Range $27.02 - $42.4
Dividend Yield 0%
Analyst Rating 100% buy
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '25124M31M93M-6.7M-6M-0.140
Q4 '24124M32M93M-16M-9M-0.080
Q3 '24116M29M87M-7.9M-940,000-0.170
Q2 '24116M30M86M-8M-1.6M-0.170
Q1 '24109M28M81M-13M-7M-0.280

Insider Transactions View All

Prange Karen filed to sell 17,828 shares at $38.1.
March 7 '25
Yuen Maggie filed to sell 8,970 shares at $24.1.
August 19 '24
Privitera Salvatore filed to buy 103,290 shares at $22.3.
May 31 '24
Noznesky Justin J filed to sell 71,284 shares at $24.1.
May 3 '24
Noznesky Justin J filed to sell 72,784 shares at $30.4.
April 3 '24

What is the Market Cap of Atricure?

The Market Cap of Atricure is $1.68B.

What is the current stock price of Atricure?

Currently, the price of one share of Atricure stock is $33.54.

How can I analyze the ATRC stock price chart for investment decisions?

The ATRC stock price chart above provides a comprehensive visual representation of Atricure's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Atricure shares. Our platform offers an up-to-date ATRC stock price chart, along with technical data analysis and alternative data insights.

Does ATRC offer dividends to its shareholders?

As of our latest update, Atricure (ATRC) does not offer dividends to its shareholders. Investors interested in Atricure should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Atricure?

Some of the similar stocks of Atricure are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Stock performance
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
Start typing below to begin.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.